Abstract
JVIR 2000; 11:1303–1307 ACUTE aortic dissection is one of the most catastrophic conditions that can affect the aorta. If the condition is left untreated, 36%–72% of patients die within 48 hours of diagnosis, and 62%–92% die within 1 week (1–5). For patients with acute Stanford type A dissections (which involve the ascending aorta), surgical intervention is performed immediately after diagnosis to avert the high risk of death due to various complications, such as cardiac tamponade, aortic regurgitation, and myocardial infarction (5,6). However, the mortality and morbidity rates after urgent surgery are still high, especially when the simultaneous replacement of ascending aorta and aortic arch is performed (7), and the selection of therapeutic approach and surgical procedures has been controversial (8,9). In certain vascular beds, such as the carotid, renal, and mesenteric, these vascular complications will dominate as the immediate cause of death. Recently, endovascular stentgrafting is emerging as a less invasive alternative to surgical graft placement for patients with aneurysmal diseases (5,10). Its efficacy and safety have been reported for the treatment of aortic aneurysms and ischemic complications (5,10,11). In this report, we describe a case of Stanford type A aortic dissection in which Palmaz stents were employed in the three major branches of the aortic arch (left subclavian, left common carotid, and right brachiocephalic arteries), to avoid further embolic complications after emergency replacement of the ascending aorta.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call